Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V Andreozzi
Prm134 - Using Adjusted Indirect Comparison in Hta to Overcome Short Follow-Up Time in Regulatory Randomized Controled Clinical Trials: Ribociclib as First-Line Therapy for Hr-Positive, Advanced Breast Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm200 - Stated Preferences for Appropriate Characteristics of Current Hepatitis C Treatment Regimens
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer
Breast Care
Surgery
Oncology
Pharmacoeconomic Analysis of Using Cyclin-Dependent Kinase 4 and 6 Inhibitors in the First Line Treatment of HR-positive HER2-negative Advanced Breast Cancer
FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
Pcn81 - Budget Impact Analysis of Cdk4/6 Inhibitors for the First Line Theraphy of Hr-Positive Her2-Negative Advanced Breast Cancer in the Russian Federation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Geburtshilfe und Frauenheilkunde
Gynecology
Midwifery
Maternity
Obstetrics
Pcn171 - A Cost-Utility Analysis of Fulvestrant Versus Anastrozole as First-Line Therapy for Oestrogen Receptor-Positive Locally Advanced and Metastatic Breast Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Reasons for Accepting or Declining to Participate in Randomized Clinical Trials for Cancer Therapy
British Journal of Cancer
Cancer Research
Oncology
Pembrolizumab as First-Line Therapy in Programmed Death Ligand 1-Positive Advanced Lung Cancer: Is It as Effective as We Think It Is?
Cancer
Cancer Research
Oncology
Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Prm258 - Methodological Approaches for Conducting Matching-Adjusted Indirect Comparisons Involving Multiple Randomized Controlled Trials
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental